Loading...

Daniel Mathalon, PhD, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address4150 Clement St
San Francisco CA 94121
Phone415-221-4810
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Improving Frontal Emotion Regulation in PTSD by Targeting Sleep
    NIH/NIMH R56MH107042Sep 20, 2016 - Aug 31, 2017
    Role: Co-Principal Investigator
    Visual and Motor Neuroplasticity in Schizophrenia
    NIH/NIMH R21MH102727Jan 1, 2014 - Dec 31, 2015
    Role: Principal Investigator
    Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression
    NIH/NCCIH R01AT004572Apr 1, 2008 - Feb 28, 2015
    Role: Co-Principal Investigator
    Functional Brain Abnormalities in the Schizophrenia Prodrome
    NIH/NIMH R01MH076989May 21, 2007 - Sep 24, 2014
    Role: Principal Investigator
    9/9-Predictors and Mechanisms of Conversion to Psychosis
    NIH/NIMH U01MH076989Apr 1, 2006 - Jun 30, 2019
    Role: Principal Investigator
    Calcium Signaling &Prefrontal Deficits in Schizophrenia
    NIH P50MH068789Dec 12, 2003 - Nov 30, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ramsay IS, Fryer S, Boos A, Roach BJ, Fisher M, Loewy R, Vinogradov S, Mathalon D. Response to Targeted Cognitive Training Correlates with Change in Thalamic Volume in a Randomized Trial for Early Schizophrenia. Neuropsychopharmacology. 2017 Sep 12. PMID: 28895568.
      View in: PubMed
    2. Forsyth JK, Bachman P, Mathalon D, Roach BJ, Ye E, Asarnow RF. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine. Schizophr Bull. 2017 Sep 01; 43(5):1123-1133. PMID: 28338977.
      View in: PubMed
    3. Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Res. 2017 Aug 31. PMID: 28886901.
      View in: PubMed
    4. Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry. 2017 Aug 09. PMID: 28792113.
      View in: PubMed
    5. Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry. 2017 Aug 03. PMID: 28771938.
      View in: PubMed
    6. Qi S, Calhoun VD, van Erp TGM, Bustillo J, Damaraju E, Turner JA, Du Y, Yang J, Chen J, Yu Q, Mathalon D, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Jiang T, Sui J. Multimodal Fusion with Reference: Searching for Joint Neuromarkers of Working Memory Deficits in Schizophrenia. IEEE Trans Med Imaging. 2017 Jul 11. PMID: 28708547.
      View in: PubMed
    7. Biagianti B, Roach BJ, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon D. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatr Electrophysiol. 2017; 3. PMID: 28845238.
      View in: PubMed
    8. Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon D, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res. 2017 Jun 01. PMID: 28578922.
      View in: PubMed
    9. Agcaoglu O, Miller R, Damaraju E, Rashid B, Bustillo J, Cetin MS, Van Erp TGM, McEwen S, Preda A, Ford JM, Lim KO, Manoach DS, Mathalon D, Potkin SG, Calhoun VD. Decreased hemispheric connectivity and decreased intra- and inter- hemisphere asymmetry of resting state functional network connectivity in schizophrenia. Brain Imaging Behav. 2017 Apr 22. PMID: 28434159.
      View in: PubMed
    10. Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon D, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Reichenberg A, Bearden CE. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol. 2017 Apr 19; 1-9. PMID: 28420458.
      View in: PubMed
    11. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon D, Woods SW. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res. 2017 Mar 31. PMID: 28372906.
      View in: PubMed
    12. Jahshan C, Wynn JK, Mathalon D, Green MF. Cognitive correlates of visual neural plasticity in schizophrenia. Schizophr Res. 2017 Mar 20. PMID: 28336195.
      View in: PubMed
    13. Hare SM, Ford JM, Ahmadi A, Damaraju E, Belger A, Bustillo J, Lee HJ, Mathalon D, Mueller BA, Preda A, van Erp TG, Potkin SG, Calhoun VD, Turner JA. Modality-Dependent Impact of Hallucinations on Low-Frequency Fluctuations in Schizophrenia. Schizophr Bull. 2017 03 01; 43(2):389-396. PMID: 27421792.
      View in: PubMed
    14. Chung Y, Haut KM, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cannon TD. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophr Res. 2017 Feb 25. PMID: 28245961.
      View in: PubMed
    15. Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon D, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, Cannon TD. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology. 2017 Oct; 42(11):2188-2195. PMID: 28186095.
      View in: PubMed
    16. Baenninger A, Palzes VA, Roach BJ, Mathalon D, Ford J, Koenig T. Abnormal Coupling Between Default Mode Network and Delta and Beta Band Brain Electric Activity in Psychotic Patients. Brain Connect. 2017 Feb; 7(1):34-44. PMID: 27897031.
      View in: PubMed
    17. Woolley JD, Chuang B, Fussell C, Scherer S, Biagianti B, Fulford D, Mathalon D, Vinogradov S. Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls. Psychol Med. 2017 May; 47(7):1311-1322. PMID: 28091349.
      View in: PubMed
    18. Subramaniam K, Ranasinghe KG, Mathalon D, Nagarajan S, Vinogradov S. Neural mechanisms of mood-induced modulation of reality monitoring in schizophrenia. Cortex. 2017 Jun; 91:271-286. PMID: 28162778.
      View in: PubMed
    19. Jeffries CD, Perkins DO, Chandler SD, Stark T, Yeo E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Glatt SJ, Tsuang M. Insights into psychosis risk from leukocyte microRNA expression. Transl Psychiatry. 2016 Dec 13; 6(12):e981. PMID: 27959328.
      View in: PubMed
    20. Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon D, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016 Dec 01; 73(12):1239-1248. PMID: 27806157.
      View in: PubMed
    21. Subramaniam K, Gill J, Slattery P, Shastri A, Mathalon D, Nagarajan S, Vinogradov S. Neural Mechanisms of Positive Mood Induced Modulation of Reality Monitoring. Front Hum Neurosci. 2016; 10:581. PMID: 27895571.
      View in: PubMed
    22. Noble S, Scheinost D, Finn ES, Shen X, Papademetris X, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon D, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Cannon TD, Constable RT. Multisite reliability of MR-based functional connectivity. Neuroimage. 2017 Feb 01; 146:959-970. PMID: 27746386.
      View in: PubMed
    23. Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, S Cadenhead K, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon D, Perkins DO, Tsuang MT, Walker EF, Woods SW. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol. 2016 Oct 05; 1-10. PMID: 27705009.
      View in: PubMed
    24. Newman E, Jernigan TL, Lisdahl KM, Tamm L, Tapert SF, Potkin SG, Mathalon D, Molina B, Bjork J, Castellanos FX, Swanson J, Kuperman JM, Bartsch H, Chen CH, Dale AM, Epstein JN, Group MN. Go/No Go task performance predicts cortical thickness in the caudal inferior frontal gyrus in young adults with and without ADHD. Brain Imaging Behav. 2016 Sep; 10(3):880-92. PMID: 26404018; PMCID: PMC4808505 [Available on 09/01/17].
    25. Rasmussen J, Casey BJ, van Erp TG, Tamm L, Epstein JN, Buss C, Bjork JM, Molina BS, Velanova K, Mathalon D, Somerville L, Swanson JM, Wigal T, Arnold LE, Potkin SG. ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging Behav. 2016 Sep; 10(3):761-71. PMID: 26489976; PMCID: PMC4840078 [Available on 09/01/17].
    26. Ford JM, Roach BJ, Palzes VA, Mathalon D. Using concurrent EEG and fMRI to probe the state of the brain in schizophrenia. Neuroimage Clin. 2016; 12:429-41. PMID: 27622140; PMCID: PMC5008052.
    27. Calhoun VD, van Erp TG, Damaraju E, Bustillo J, Turner JA, Mathalon D, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Birn F. Supervised multimodal fusion and its application in searching joint neuromarkers of working memory deficits in schizophrenia. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug; 2016:4021-4026. PMID: 28269167.
      View in: PubMed
    28. Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AF, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA, Carter CS, Cook EH, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon D, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA, Zubieta JK. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. Biol Psychiatry. 2016 Jul 15; 80(2):84-86. PMID: 27346079.
      View in: PubMed
    29. Hough CM, Luks TL, Lai K, Vigil O, Guillory S, Nongpiur A, Fekri SM, Kupferman E, Mathalon D, Mathews CA. Comparison of brain activation patterns during executive function tasks in hoarding disorder and non-hoarding OCD. Psychiatry Res. 2016 Sep 30; 255:50-9. PMID: 27522332; PMCID: PMC5014569 [Available on 09/30/17].
    30. Kort NS, Ford JM, Roach BJ, Gunduz-Bruce H, Krystal JH, Jaeger J, Reinhart RM, Mathalon D. Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia. Biol Psychiatry. 2017 Mar 15; 81(6):514-524. PMID: 27647218.
      View in: PubMed
    31. Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Kattan MW. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016 Oct 01; 173(10):980-988. PMID: 27363508.
      View in: PubMed
    32. Buchy L, Mathalon D, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Res. 2016 Aug 30; 254:3-9. PMID: 27289213; PMCID: PMC5037437 [Available on 08/30/17].
    33. Marshall C, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Res. 2016 Aug 30; 242:61-66. PMID: 27259137.
      View in: PubMed
    34. Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016 Jul; 174(1-3):77-81. PMID: 27165121; PMCID: PMC5037435 [Available on 07/01/17].
    35. McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Goldberg TE, Harvey PD, Cornblatt BA. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophr Bull. 2016 Sep; 42(5):1234-42. PMID: 27105902; PMCID: PMC4988745 [Available on 09/01/17].
    36. Fryer SL, Roach BJ, Wiley K, Loewy RL, Ford JM, Mathalon D. Reduced Amplitude of Low-Frequency Brain Oscillations in the Psychosis Risk Syndrome and Early Illness Schizophrenia. Neuropsychopharmacology. 2016 Aug; 41(9):2388-98. PMID: 27067126; PMCID: PMC4946069 [Available on 08/01/17].
    37. Miller RL, Yaesoubi M, Turner JA, Mathalon D, Preda A, Pearlson G, Adali T, Calhoun VD. Higher Dimensional Meta-State Analysis Reveals Reduced Resting fMRI Connectivity Dynamism in Schizophrenia Patients. PLoS One. 2016; 11(3):e0149849. PMID: 26981625; PMCID: PMC4794213.
    38. Loewy R, Fisher M, Schlosser DA, Biagianti B, Stuart B, Mathalon D, Vinogradov S. Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull. 2016 Jul; 42 Suppl 1:S118-26. PMID: 26903238; PMCID: PMC4960436 [Available on 07/01/17].
    39. Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, Woods SW, Walker EF. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophr Res. 2016 Apr; 172(1-3):29-34. PMID: 26905038; PMCID: PMC4821739 [Available on 04/01/17].
    40. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. PMID: 26896388.
      View in: PubMed
    41. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol. 2016 Apr; 51(4):497-503. PMID: 26851943.
      View in: PubMed
    42. Eisendrath SJ, Gillung E, Delucchi KL, Segal ZV, Nelson JC, McInnes LA, Mathalon D, Feldman MD. A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression. Psychother Psychosom. 2016; 85(2):99-110. PMID: 26808973; PMCID: PMC4756643 [Available on 01/26/17].
    43. Piskulic D, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophr Res. 2016 Mar; 171(1-3):176-81. PMID: 26785807; PMCID: PMC5037438 [Available on 03/01/17].
    44. Mifsud NG, Oestreich LK, Jack BN, Ford JM, Roach BJ, Mathalon D, Whitford TJ. Self-initiated actions result in suppressed auditory but amplified visual evoked components in healthy participants. Psychophysiology. 2016 May; 53(5):723-32. PMID: 26751981.
      View in: PubMed
    45. Forsyth JK, Bachman P, Mathalon D, Roach BJ, Asarnow RF. Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain. Proc Natl Acad Sci U S A. 2015 Dec 15; 112(50):15331-6. PMID: 26621715; PMCID: PMC4687562.
    46. Buchy L, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Res. 2015 Dec 30; 230(3):878-84. PMID: 26626949; PMCID: PMC5037441 [Available on 12/30/16].
    47. Buchy L, Cannon TD, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry. 2015 Nov 09; 15:276. PMID: 26553191; PMCID: PMC4640353.
    48. van Erp TG, Preda A, Turner JA, Callahan S, Calhoun VD, Bustillo JR, Lim KO, Mueller B, Brown GG, Vaidya JG, McEwen S, Belger A, Voyvodic J, Mathalon D, Nguyen D, Ford JM, Potkin SG. Neuropsychological profile in adult schizophrenia measured with the CMINDS. Psychiatry Res. 2015 Dec 30; 230(3):826-34. PMID: 26586142; PMCID: PMC4692593 [Available on 12/30/16].
    49. Shaffer JJ, Peterson MJ, McMahon MA, Bizzell J, Calhoun V, van Erp TG, Ford JM, Lauriello J, Lim KO, Manoach DS, McEwen SC, Mathalon D, O'Leary D, Potkin SG, Preda A, Turner J, Voyvodic J, Wible CG, Belger A. Neural Correlates of Schizophrenia Negative Symptoms: Distinct Subtypes Impact Dissociable Brain Circuits. Mol Neuropsychiatry. 2015 Dec; 1(4):191-200. PMID: 27606313; PMCID: PMC4996000 [Available on 12/01/16].
    50. McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry. 2015 Oct 12. PMID: 26456932.
      View in: PubMed
    51. Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon D, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res. 2015 Dec; 169(1-3):169-177. PMID: 26441004.
      View in: PubMed
    52. Mathews CA, Perez VB, Roach BJ, Fekri S, Vigil O, Kupferman E, Mathalon D. Error-related brain activity dissociates hoarding disorder from obsessive-compulsive disorder. Psychol Med. 2016 Jan; 46(2):367-79. PMID: 26415671.
      View in: PubMed
    53. Aranovich GJ, McClure SM, Fryer S, Mathalon D. The effect of cognitive challenge on delay discounting. Neuroimage. 2016 Jan 01; 124(Pt A):733-739. PMID: 26394377.
      View in: PubMed
    54. Keator DB, van Erp TG, Turner JA, Glover GH, Mueller BA, Liu TT, Voyvodic JT, Rasmussen J, Calhoun VD, Lee HJ, Toga AW, McEwen S, Ford JM, Mathalon D, Diaz M, O'Leary DS, Jeremy Bockholt H, Gadde S, Preda A, Wible CG, Stern HS, Belger A, McCarthy G, Ozyurt B, Potkin SG. The Function Biomedical Informatics Research Network Data Repository. Neuroimage. 2016 Jan 01; 124(Pt B):1074-9. PMID: 26364863; PMCID: PMC4651841 [Available on 01/01/17].
    55. Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon D, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry. 2015 Sep; 72(9):882-91. PMID: 26267151; PMCID: PMC4892891.
    56. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon D, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 Apr; 21(4):585. PMID: 26283641.
      View in: PubMed
    57. Mathalon D, Sohal VS. Neural Oscillations and Synchrony in Brain Dysfunction and Neuropsychiatric Disorders: It's About Time. JAMA Psychiatry. 2015 Aug; 72(8):840-4. PMID: 26039190.
      View in: PubMed
    58. Miller RL, Erhardt EB, Agcaoglu O, Allen EA, Michael AM, Turner JA, Bustillo J, Ford JM, Mathalon D, Van Erp TG, Potkin S, Preda A, Pearlson G, Calhoun VD. Multidimensional frequency domain analysis of full-volume fMRI reveals significant effects of age, gender, and mental illness on the spatiotemporal organization of resting-state brain activity. Front Neurosci. 2015; 9:203. PMID: 26136646; PMCID: PMC4468831.
    59. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon D, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 Apr; 21(4):547-53. PMID: 26033243; PMCID: PMC4668237.
    60. Eisendrath SJ, Gillung E, Delucchi K, Mathalon D, Yang TT, Satre DD, Rosser R, Sipe WE, Wolkowitz OM. A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder. Mindfulness (N Y). 2015 Jun 01; 6(3):475-482. PMID: 26085853.
      View in: PubMed
    61. Oestreich LK, Mifsud NG, Ford JM, Roach BJ, Mathalon D, Whitford TJ. Subnormal sensory attenuation to self-generated speech in schizotypy: Electrophysiological evidence for a 'continuum of psychosis'. Int J Psychophysiol. 2015 Aug; 97(2):131-8. PMID: 26027781; PMCID: PMC4607510.
    62. Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Mathalon D, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. Demographic correlates of attenuated positive psychotic symptoms. Schizophr Res. 2015 Aug; 166(1-3):31-6. PMID: 25999040; PMCID: PMC4767147.
    63. Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Heinssen R, Addington J. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophr Res Cogn. 2015 Sep; 2(3):133-139. PMID: 27695675.
      View in: PubMed
    64. Fryer SL, Roach BJ, Ford JM, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya J, Potkin SG, Mathalon D. Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. Neuropsychopharmacology. 2015 Nov; 40(12):2705-14. PMID: 25944410; PMCID: PMC4864646 [Available on 11/01/16].
    65. Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, Cannon TD. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Mol Neuropsychiatry. 2015 May 01; 1(1):13-22. PMID: 26005673.
      View in: PubMed
    66. Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, McGlashan TH. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis. 2015 May; 203(5):328-35. PMID: 25919383; PMCID: PMC4417745.
    67. Cortes-Briones J, Skosnik PD, Mathalon D, Cahill J, Pittman B, Williams A, Sewell RA, Ranganathan M, Roach B, Ford J, D'Souza DC. ?9-THC Disrupts Gamma (?)-Band Neural Oscillations in Humans. Neuropsychopharmacology. 2015 Aug; 40(9):2124-34. PMID: 25709097; PMCID: PMC4613601.
    68. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Heinssen R, Addington J. Core Schemas in Youth at Clinical High Risk for Psychosis. Behav Cogn Psychother. 2016 Mar; 44(2):203-13. PMID: 25896713.
      View in: PubMed
    69. Oestreich LK, Mifsud NG, Ford JM, Roach BJ, Mathalon D, Whitford TJ. Cortical Suppression to Delayed Self-Initiated Auditory Stimuli in Schizotypy: Neurophysiological Evidence for a Continuum of Psychosis. Clin EEG Neurosci. 2016 Jan; 47(1):3-10. PMID: 25898988.
      View in: PubMed
    70. Lee HJ, Preda A, Ford JM, Mathalon D, Keator DB, van Erp TG, Turner JA, Potkin SG. Functional magnetic resonance imaging of motor cortex activation in schizophrenia. J Korean Med Sci. 2015 May; 30(5):625-31. PMID: 25931795; PMCID: PMC4414648.
    71. Cortes-Briones JA, Cahill JD, Skosnik PD, Mathalon D, Williams A, Sewell RA, Roach BJ, Ford JM, Ranganathan M, D'Souza DC. The psychosis-like effects of ?(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans. Biol Psychiatry. 2015 Dec 01; 78(11):805-13. PMID: 25913109; PMCID: PMC4627857 [Available on 12/01/16].
    72. Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon D, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Constable T, Cannon TD. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Hum Brain Mapp. 2015 Jul; 36(7):2558-79. PMID: 25821147; PMCID: PMC4478164.
    73. Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J. Substance use in individuals at clinical high risk of psychosis. Psychol Med. 2015 Aug; 45(11):2275-84. PMID: 25727300.
      View in: PubMed
    74. Hay RA, Roach BJ, Srihari VH, Woods SW, Ford JM, Mathalon D. Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biol Psychol. 2015 Feb; 105:130-7. PMID: 25603283; PMCID: PMC4336819.
    75. Woolley JD, Lam O, Chuang B, Ford JM, Mathalon D, Vinogradov S. Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia. Psychoneuroendocrinology. 2015 Mar; 53:217-22. PMID: 25637811; PMCID: PMC4503321.
    76. Gupta CN, Calhoun VD, Rachakonda S, Chen J, Patel V, Liu J, Segall J, Franke B, Zwiers MP, Arias-Vasquez A, Buitelaar J, Fisher SE, Fernandez G, van Erp TG, Potkin S, Ford J, Mathalon D, McEwen S, Lee HJ, Mueller BA, Greve DN, Andreassen O, Agartz I, Gollub RL, Sponheim SR, Ehrlich S, Wang L, Pearlson G, Glahn DC, Sprooten E, Mayer AR, Stephen J, Jung RE, Canive J, Bustillo J, Turner JA. Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis. Schizophr Bull. 2015 Sep; 41(5):1133-42. PMID: 25548384; PMCID: PMC4535628.
    77. Trotman HD, Holtzman CW, Walker EF, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Mathalon D, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res. 2014 Dec; 160(1-3):104-9. PMID: 25443665; PMCID: PMC4593703.
    78. Jackson F, Foti D, Kotov R, Perlman G, Mathalon D, Proudfit GH. An incongruent reality: the N400 in relation to psychosis and recovery. Schizophr Res. 2014 Dec; 160(1-3):208-15. PMID: 25449716; PMCID: PMC4258120.
    79. Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull. 2015 Mar; 41(2):419-28. PMID: 25103207; PMCID: PMC4332942.
    80. Fulford D, Pearson R, Stuart BK, Fisher M, Mathalon D, Vinogradov S, Loewy RL. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations. Psychiatry Res. 2014 Dec 30; 220(3):1077-83. PMID: 25278477; PMCID: PMC4258147.
    81. Arbabshirani MR, Damaraju E, Phlypo R, Plis S, Allen E, Ma S, Mathalon D, Preda A, Vaidya JG, Adali T, Calhoun VD. Impact of autocorrelation on functional connectivity. Neuroimage. 2014 Nov 15; 102 Pt 2:294-308. PMID: 25072392; PMCID: PMC4253536.
    82. Damaraju E, Allen EA, Belger A, Ford JM, McEwen S, Mathalon D, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TG, Calhoun VD. Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia. Neuroimage Clin. 2014; 5:298-308. PMID: 25161896; PMCID: PMC4141977.
    83. Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015 Jan 15; 77(2):147-57. PMID: 25034946; PMCID: PMC4264996.
    84. Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon D, Vinogradov S. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology. 2014 Sep; 47:116-25. PMID: 25001961; PMCID: PMC4280262.
    85. Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon D, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos HW, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage. 2014 Aug 15; 97:41-52. PMID: 24736173; PMCID: PMC4065837.
    86. Ford JM, Palzes VA, Roach BJ, Potkin SG, van Erp TG, Turner JA, Mueller BA, Calhoun VD, Voyvodic J, Belger A, Bustillo J, Vaidya JG, Preda A, McEwen SC, Mathalon D. Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. Schizophr Bull. 2015 Jan; 41(1):223-32. PMID: 24619536; PMCID: PMC4266287.
    87. Eisendrath SJ, Gillung EP, Delucchi KL, Chartier M, Mathalon D, Sullivan JC, Segal ZV, Feldman MD. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol. BMC Complement Altern Med. 2014 Mar 11; 14:95. PMID: 24612825; PMCID: PMC3995768.
    88. van Erp TG, Greve DN, Rasmussen J, Turner J, Calhoun VD, Young S, Mueller B, Brown GG, McCarthy G, Glover GH, Lim KO, Bustillo JR, Belger A, McEwen S, Voyvodic J, Mathalon D, Keator D, Preda A, Nguyen D, Ford JM, Potkin SG. A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. Psychiatry Res. 2014 Apr 30; 222(1-2):10-6. PMID: 24650452; PMCID: PMC4059082.
    89. Mathalon D, Ahn KH, Perry EB, Cho HS, Roach BJ, Blais RK, Bhakta S, Ranganathan M, Ford JM, D'Souza DC. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. Front Psychiatry. 2014; 5:3. PMID: 24478731; PMCID: PMC3900858.
    90. Wang J, Mathalon D, Roach BJ, Reilly J, Keedy SK, Sweeney JA, Ford JM. Action planning and predictive coding when speaking. Neuroimage. 2014 May 01; 91:91-8. PMID: 24423729; PMCID: PMC3965634.
    91. Sitek KR, Mathalon D, Roach BJ, Houde JF, Niziolek CA, Ford JM. Auditory cortex processes variation in our own speech. PLoS One. 2013; 8(12):e82925. PMID: 24349399; PMCID: PMC3862760.
    92. van Erp TG, Preda A, Nguyen D, Faziola L, Turner J, Bustillo J, Belger A, Lim KO, McEwen S, Voyvodic J, Mathalon D, Ford J, Potkin SG. Converting positive and negative symptom scores between PANSS and SAPS/SANS. Schizophr Res. 2014 Jan; 152(1):289-94. PMID: 24332632; PMCID: PMC3966195.
    93. Perez VB, Woods SW, Roach BJ, Ford JM, McGlashan TH, Srihari VH, Mathalon D. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. Biol Psychiatry. 2014 Mar 15; 75(6):459-69. PMID: 24050720; PMCID: PMC4028131.
    94. Fryer SL, Woods SW, Kiehl KA, Calhoun VD, Pearlson GD, Roach BJ, Ford JM, Srihari VH, McGlashan TH, Mathalon D. Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis. Front Psychiatry. 2013; 4:92. PMID: 24032017; PMCID: PMC3768116.
    95. Cannon TD, Sun F, McEwen SJ, Papademetris X, He G, van Erp TG, Jacobson A, Bearden CE, Walker E, Hu X, Zhou L, Seidman LJ, Thermenos HW, Cornblatt B, Olvet DM, Perkins D, Belger A, Cadenhead K, Tsuang M, Mirzakhanian H, Addington J, Frayne R, Woods SW, McGlashan TH, Constable RT, Qiu M, Mathalon D, Thompson P, Toga AW. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum Brain Mapp. 2014 May; 35(5):2424-34. PMID: 23982962; PMCID: PMC3843968.
    96. Turner JA, Damaraju E, van Erp TG, Mathalon D, Ford JM, Voyvodic J, Mueller BA, Belger A, Bustillo J, McEwen S, Potkin SG, Calhoun VD. A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia. Front Neurosci. 2013; 7:137. PMID: 23964193; PMCID: PMC3737471.
    97. Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon D, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, Duncan E, Johannesen J, León-Ortiz P, Light G, Mondragón A, Niznikiewicz M, Nunag J, Roach BJ, Solís-Vivanco R. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 2013 Aug 07; 24(11):626-30. PMID: 23799460; PMCID: PMC4135529.
    98. van Erp TG, Guella I, Vawter MP, Turner J, Brown GG, McCarthy G, Greve DN, Glover GH, Calhoun VD, Lim KO, Bustillo JR, Belger A, Ford JM, Mathalon D, Diaz M, Preda A, Nguyen D, Macciardi F, Potkin SG. Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. Biol Psychiatry. 2014 Mar 01; 75(5):398-405. PMID: 23910899; PMCID: PMC4428556.
    99. Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon D, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013 Aug; 148(1-3):99-104. PMID: 23787224; PMCID: PMC3867209.
    100. Ford JM, Palzes VA, Roach BJ, Mathalon D. Did I do that? Abnormal predictive processes in schizophrenia when button pressing to deliver a tone. Schizophr Bull. 2014 Jul; 40(4):804-12. PMID: 23754836; PMCID: PMC4059422.
    101. Thomas ML, Brown GG, Thompson WK, Voyvodic J, Greve DN, Turner JA, Mathalon D, Ford J, Wible CG, Potkin SG. An application of item response theory to fMRI data: prospects and pitfalls. Psychiatry Res. 2013 Jun 30; 212(3):167-74. PMID: 23642468; PMCID: PMC3775707.
    102. Fulford D, Niendam TA, Floyd EG, Carter CS, Mathalon D, Vinogradov S, Stuart BK, Loewy RL. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr Res. 2013 Jun; 147(1):125-131. PMID: 23587696; PMCID: PMC3663589.
    103. Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon D, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 2013 Sep 15; 74(6):410-7. PMID: 23562006; PMCID: PMC3707958.
    104. Perez VB, Roach BJ, Woods SW, Srihari VH, McGlashan TH, Ford JM, Mathalon D. Early auditory gamma-band responses in patients at clinical high risk for schizophrenia. Suppl Clin Neurophysiol. 2013; 62:147-62. PMID: 24053038; PMCID: PMC4120874.
    105. Roach BJ, Ford JM, Hoffman RE, Mathalon D. Converging evidence for gamma synchrony deficits in schizophrenia. Suppl Clin Neurophysiol. 2013; 62:163-80. PMID: 24053039; PMCID: PMC4165558.
    106. Ford JM, Mathalon D, Roach BJ, Keedy SK, Reilly JL, Gershon ES, Sweeney JA. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80. PMID: 23155183; PMCID: PMC3796076.
    107. Fryer SL, Jorgensen KW, Yetter EJ, Daurignac EC, Watson TD, Shanbhag H, Krystal JH, Mathalon D. Differential brain response to alcohol cue distractors across stages of alcohol dependence. Biol Psychol. 2013 Feb; 92(2):282-91. PMID: 23131612; PMCID: PMC3947923.
    108. Addington J, Cadenhead KS, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012 Dec; 142(1-3):77-82. PMID: 23043872; PMCID: PMC3502644.
    109. Mathalon D, Ford JM. Neurobiology of schizophrenia: search for the elusive correlation with symptoms. Front Hum Neurosci. 2012; 6:136. PMID: 22654745; PMCID: PMC3360476.
    110. Turner JA, Chen H, Mathalon D, Allen EA, Mayer AR, Abbott CC, Calhoun VD, Bustillo J. Reliability of the amplitude of low-frequency fluctuations in resting state fMRI in chronic schizophrenia. Psychiatry Res. 2012 Mar 31; 201(3):253-5. PMID: 22541511; PMCID: PMC3361647.
    111. Cavus I, Reinhart RM, Roach BJ, Gueorguieva R, Teyler TJ, Clapp WC, Ford JM, Krystal JH, Mathalon D. Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry. 2012 Mar 15; 71(6):512-20. PMID: 22364738; PMCID: PMC3292767.
    112. Ford JM, Dierks T, Fisher DJ, Herrmann CS, Hubl D, Kindler J, Koenig T, Mathalon D, Spencer KM, Strik W, van Lutterveld R. Neurophysiological studies of auditory verbal hallucinations. Schizophr Bull. 2012 Jun; 38(4):715-23. PMID: 22368236; PMCID: PMC3406526.
    113. Liu J, Ghassemi MM, Michael AM, Boutte D, Wells W, Perrone-Bizzozero N, Macciardi F, Mathalon D, Ford JM, Potkin SG, Turner JA, Calhoun VD. An ICA with reference approach in identification of genetic variation and associated brain networks. Front Hum Neurosci. 2012; 6:21. PMID: 22371699; PMCID: PMC3284145.
    114. D'Souza DC, Fridberg DJ, Skosnik PD, Williams A, Roach B, Singh N, Carbuto M, Elander J, Schnakenberg A, Pittman B, Sewell RA, Ranganathan M, Mathalon D. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous ??-THC in humans. Neuropsychopharmacology. 2012 Jun; 37(7):1632-46. PMID: 22334121; PMCID: PMC3358754.
    115. Glover GH, Mueller BA, Turner JA, van Erp TG, Liu TT, Greve DN, Voyvodic JT, Rasmussen J, Brown GG, Keator DB, Calhoun VD, Lee HJ, Ford JM, Mathalon D, Diaz M, O'Leary DS, Gadde S, Preda A, Lim KO, Wible CG, Stern HS, Belger A, McCarthy G, Ozyurt B, Potkin SG. Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging. 2012 Jul; 36(1):39-54. PMID: 22314879; PMCID: PMC3349791.
    116. Ford JM, Perez VB, Mathalon D. Neurophysiology of a possible fundamental deficit in schizophrenia. World Psychiatry. 2012 Feb; 11(1):58-60. PMID: 22295012; PMCID: PMC3266755.
    117. Mathews CA, Perez VB, Delucchi KL, Mathalon D. Error-related negativity in individuals with obsessive-compulsive symptoms: toward an understanding of hoarding behaviors. Biol Psychol. 2012 Feb; 89(2):487-94. PMID: 22227169; PMCID: PMC3292435.
    118. Perez VB, Ford JM, Roach BJ, Woods SW, McGlashan TH, Srihari VH, Loewy RL, Vinogradov S, Mathalon D. Error monitoring dysfunction across the illness course of schizophrenia. J Abnorm Psychol. 2012 May; 121(2):372-87. PMID: 22060947; PMCID: PMC3358508.
    119. Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC, Ford JM, Krystal JH, Mathalon D. Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry. 2012 Jun 01; 71(11):969-77. PMID: 22036036; PMCID: PMC3290754.
    120. Perez VB, Ford JM, Roach BJ, Loewy RL, Stuart BK, Vinogradov S, Mathalon D. Auditory cortex responsiveness during talking and listening: early illness schizophrenia and patients at clinical high-risk for psychosis. Schizophr Bull. 2012 Nov; 38(6):1216-24. PMID: 21993915; PMCID: PMC3494053.
    121. Mathalon D. Challenges associated with application of clinical staging models to psychotic disorders. Biol Psychiatry. 2011 Oct 01; 70(7):600-1. PMID: 21924130; PMCID: PMC4096294.
    122. Ford JM, Mathalon D. Anticipating the future: automatic prediction failures in schizophrenia. Int J Psychophysiol. 2012 Feb; 83(2):232-9. PMID: 21959054; PMCID: PMC3288329.
    123. Barch DM, Mathalon D. Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations. Biol Psychiatry. 2011 Jul 01; 70(1):13-8. PMID: 21334602; PMCID: PMC4073232.
    124. Colrain IM, Sullivan EV, Ford JM, Mathalon D, McPherson SL, Roach BJ, Crowley KE, Pfefferbaum A. Frontally mediated inhibitory processing and white matter microstructure: age and alcoholism effects. Psychopharmacology (Berl). 2011 Feb; 213(4):669-79. PMID: 21161189; PMCID: PMC3033525.
    125. Luck SJ, Mathalon D, O'Donnell BF, Hämäläinen MS, Spencer KM, Javitt DC, Uhlhaas PJ. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry. 2011 Jul 01; 70(1):28-34. PMID: 21111401; PMCID: PMC3116072.
    126. Greve DN, Mueller BA, Liu T, Turner JA, Voyvodic J, Yetter E, Diaz M, McCarthy G, Wallace S, Roach BJ, Ford JM, Mathalon D, Calhoun VD, Wible CG, Brown GG, Potkin SG, Glover G. A novel method for quantifying scanner instability in fMRI. Magn Reson Med. 2011 Apr; 65(4):1053-61. PMID: 21413069; PMCID: PMC3117086.
    127. Chen CM, Mathalon D, Roach BJ, Cavus I, Spencer DD, Ford JM. The corollary discharge in humans is related to synchronous neural oscillations. J Cogn Neurosci. 2011 Oct; 23(10):2892-904. PMID: 20946054; PMCID: PMC4155919.
    128. Brown GG, Mathalon D, Stern H, Ford J, Mueller B, Greve DN, McCarthy G, Voyvodic J, Glover G, Diaz M, Yetter E, Ozyurt IB, Jorgensen KW, Wible CG, Turner JA, Thompson WK, Potkin SG. Multisite reliability of cognitive BOLD data. Neuroimage. 2011 Feb 01; 54(3):2163-75. PMID: 20932915; PMCID: PMC3009557.
    129. Whitford TJ, Ford JM, Mathalon D, Kubicki M, Shenton ME. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull. 2012 May; 38(3):486-94. PMID: 20855415; PMCID: PMC3329979.
    130. Reinhart RM, Mathalon D, Roach BJ, Ford JM. Relationships between pre-stimulus ? power and subsequent P300 and reaction time breakdown in schizophrenia. Int J Psychophysiol. 2011 Jan; 79(1):16-24. PMID: 20816708; PMCID: PMC3033488.
    131. Kirk IJ, McNair NA, Hamm JP, Clapp WC, Mathalon D, Cavus I, Teyler TJ. Long-term potentiation (LTP) of human sensory-evoked potentials. Wiley Interdiscip Rev Cogn Sci. 2010 Sep; 1(5):766-773. PMID: 26271660.
      View in: PubMed
    132. Whitford TJ, Mathalon D, Shenton ME, Roach BJ, Bammer R, Adcock RA, Bouix S, Kubicki M, De Siebenthal J, Rausch AC, Schneiderman JS, Ford JM. Electrophysiological and diffusion tensor imaging evidence of delayed corollary discharges in patients with schizophrenia. Psychol Med. 2011 May; 41(5):959-69. PMID: 20663254; PMCID: PMC3807011.
    133. Ford JM, Roach BJ, Mathalon D. Assessing corollary discharge in humans using noninvasive neurophysiological methods. Nat Protoc. 2010 Jun; 5(6):1160-8. PMID: 20539291; PMCID: PMC4051441.
    134. Ford JM, Roach BJ, Miller RM, Duncan CC, Hoffman RE, Mathalon D. When it's time for a change: failures to track context in schizophrenia. Int J Psychophysiol. 2010 Oct; 78(1):3-13. PMID: 20580752; PMCID: PMC4143242.
    135. Yun RJ, Krystal JH, Mathalon D. Working memory overload: fronto-limbic interactions and effects on subsequent working memory function. Brain Imaging Behav. 2010 Mar; 4(1):96-108. PMID: 20503117; PMCID: PMC2854358.
    136. Mathalon D, Hoffman RE, Watson TD, Miller RM, Roach BJ, Ford JM. Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder. Front Hum Neurosci. 2010; 3:70. PMID: 20140266; PMCID: PMC2816168.
    137. Mathalon D, Roach BJ, Ford JM. Automatic semantic priming abnormalities in schizophrenia. Int J Psychophysiol. 2010 Feb; 75(2):157-66. PMID: 19995582; PMCID: PMC4106427.
    138. Kim DI, Manoach DS, Mathalon D, Turner JA, Mannell M, Brown GG, Ford JM, Gollub RL, White T, Wible C, Belger A, Bockholt HJ, Clark VP, Lauriello J, O'Leary D, Mueller BA, Lim KO, Andreasen N, Potkin SG, Calhoun VD. Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp. 2009 Nov; 30(11):3795-811. PMID: 19434601; PMCID: PMC3058491.
    139. Mathalon D, Jorgensen KW, Roach BJ, Ford JM. Error detection failures in schizophrenia: ERPs and FMRI. Int J Psychophysiol. 2009 Aug; 73(2):109-17. PMID: 19414043; PMCID: PMC4005823.
    140. Kim DI, Mathalon D, Ford JM, Mannell M, Turner JA, Brown GG, Belger A, Gollub R, Lauriello J, Wible C, O'Leary D, Lim K, Toga A, Potkin SG, Birn F, Calhoun VD. Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN study. Schizophr Bull. 2009 Jan; 35(1):67-81. PMID: 19074498; PMCID: PMC2643962.
    141. Potkin SG, Turner JA, Brown GG, McCarthy G, Greve DN, Glover GH, Manoach DS, Belger A, Diaz M, Wible CG, Ford JM, Mathalon D, Gollub R, Lauriello J, O'Leary D, van Erp TG, Toga AW, Preda A, Lim KO. Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr Bull. 2009 Jan; 35(1):19-31. PMID: 19042912; PMCID: PMC2643959.
    142. Brown GG, McCarthy G, Bischoff-Grethe A, Ozyurt B, Greve D, Potkin SG, Turner JA, Notestine R, Calhoun VD, Ford JM, Mathalon D, Manoach DS, Gadde S, Glover GH, Wible CG, Belger A, Gollub RL, Lauriello J, O'Leary D, Lim KO. Brain-performance correlates of working memory retrieval in schizophrenia: a cognitive modeling approach. Schizophr Bull. 2009 Jan; 35(1):32-46. PMID: 19023127; PMCID: PMC2643949.
    143. Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull. 2009 Jan; 35(1):96-108. PMID: 19023125; PMCID: PMC2643953.
    144. Wible CG, Lee K, Molina I, Hashimoto R, Preus AP, Roach BJ, Ford JM, Mathalon D, McCarthey G, Turner JA, Potkin SG, O'Leary D, Belger A, Diaz M, Voyvodic J, Brown GG, Notestine R, Greve D, Lauriello J. fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull. 2009 Jan; 35(1):47-57. PMID: 18990710; PMCID: PMC2643958.
    145. Ford JM, Roach BJ, Jorgensen KW, Turner JA, Brown GG, Notestine R, Bischoff-Grethe A, Greve D, Wible C, Lauriello J, Belger A, Mueller BA, Calhoun V, Preda A, Keator D, O'Leary DS, Lim KO, Glover G, Potkin SG, Mathalon D. Tuning in to the voices: a multisite FMRI study of auditory hallucinations. Schizophr Bull. 2009 Jan; 35(1):58-66. PMID: 18987102; PMCID: PMC2643968.
    146. Watson TD, Petrakis IL, Edgecombe J, Perrino A, Krystal JH, Mathalon D. Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission. Int J Neuropsychopharmacol. 2009 Apr; 12(3):357-70. PMID: 18771605; PMCID: PMC2900256.
    147. Roach BJ, Mathalon D. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr Bull. 2008 Sep; 34(5):907-26. PMID: 18684772; PMCID: PMC2632478.
    148. Meda SA, Bhattarai M, Morris NA, Astur RS, Calhoun VD, Mathalon D, Kiehl KA, Pearlson GD. An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients. Schizophr Res. 2008 Sep; 104(1-3):85-95. PMID: 18678469; PMCID: PMC2577216.
    149. Mathalon D, Ford JM. Divergent approaches converge on frontal lobe dysfunction in schizophrenia. Am J Psychiatry. 2008 Aug; 165(8):944-8. PMID: 18676596; PMCID: PMC2671635.
    150. Friedman L, Stern H, Brown GG, Mathalon D, Turner J, Glover GH, Gollub RL, Lauriello J, Lim KO, Cannon T, Greve DN, Bockholt HJ, Belger A, Mueller B, Doty MJ, He J, Wells W, Smyth P, Pieper S, Kim S, Kubicki M, Vangel M, Potkin SG. Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp. 2008 Aug; 29(8):958-72. PMID: 17636563; PMCID: PMC3670112.
    151. Ford JM, Mathalon D. Neural synchrony in schizophrenia. Schizophr Bull. 2008 Sep; 34(5):904-6. PMID: 18658126; PMCID: PMC2632484.
    152. Ford JM, Roach BJ, Hoffman RS, Mathalon D. The dependence of P300 amplitude on gamma synchrony breaks down in schizophrenia. Brain Res. 2008 Oct 15; 1235:133-42. PMID: 18621027; PMCID: PMC3230270.
    153. Mathalon D, Ford JM. Corollary discharge dysfunction in schizophrenia: evidence for an elemental deficit. Clin EEG Neurosci. 2008 Apr; 39(2):82-6. PMID: 18450174.
      View in: PubMed
    154. Friedman L, Turner JA, Stern H, Mathalon D, Trondsen LC, Potkin SG. Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls. Neuroimage. 2008 Apr 15; 40(3):1181-94. PMID: 18289881; PMCID: PMC2312339.
    155. Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, Mathalon D, Miller TJ, McGlashan TH. Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br J Psychiatry Suppl. 2007 Dec; 51:s96-101. PMID: 18055946.
      View in: PubMed
    156. Skelly LR, Calhoun V, Meda SA, Kim J, Mathalon D, Pearlson GD. Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr Res. 2008 Jan; 98(1-3):157-62. PMID: 18031994; PMCID: PMC2668961.
    157. Ford JM, Roach BJ, Faustman WO, Mathalon D. Out-of-synch and out-of-sorts: dysfunction of motor-sensory communication in schizophrenia. Biol Psychiatry. 2008 Apr 15; 63(8):736-43. PMID: 17981264; PMCID: PMC2330266.
    158. Ford JM, Gray M, Faustman WO, Roach BJ, Mathalon D. Dissecting corollary discharge dysfunction in schizophrenia. Psychophysiology. 2007 Jul; 44(4):522-9. PMID: 17565658.
      View in: PubMed
    159. Ford JM, Krystal JH, Mathalon D. Neural synchrony in schizophrenia: from networks to new treatments. Schizophr Bull. 2007 Jul; 33(4):848-52. PMID: 17567628; PMCID: PMC2632315.
    160. Ford JM, Roach BJ, Faustman WO, Mathalon D. Synch before you speak: auditory hallucinations in schizophrenia. Am J Psychiatry. 2007 Mar; 164(3):458-66. PMID: 17329471.
      View in: PubMed
    161. Heinks-Maldonado TH, Mathalon D, Houde JF, Gray M, Faustman WO, Ford JM. Relationship of imprecise corollary discharge in schizophrenia to auditory hallucinations. Arch Gen Psychiatry. 2007 Mar; 64(3):286-96. PMID: 17339517.
      View in: PubMed
    162. Johnson MR, Morris NA, Astur RS, Calhoun VD, Mathalon D, Kiehl KA, Pearlson GD. A functional magnetic resonance imaging study of working memory abnormalities in schizophrenia. Biol Psychiatry. 2006 Jul 01; 60(1):11-21. PMID: 16503328.
      View in: PubMed
    163. Li CS, Krystal JH, Mathalon D. Fore-period effect and stop-signal reaction time. Exp Brain Res. 2005 Nov; 167(2):305-9. PMID: 16160823.
      View in: PubMed
    164. Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon D, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. 2005 Sep 01; 58(5):424-8. PMID: 15993857.
      View in: PubMed
    165. Ford JM, Mathalon D. Corollary discharge dysfunction in schizophrenia: can it explain auditory hallucinations? Int J Psychophysiol. 2005 Nov-Dec; 58(2-3):179-89. PMID: 16137779.
      View in: PubMed
    166. Ford JM, Gray M, Faustman WO, Heinks TH, Mathalon D. Reduced gamma-band coherence to distorted feedback during speech when what you say is not what you hear. Int J Psychophysiol. 2005 Aug; 57(2):143-50. PMID: 15967529.
      View in: PubMed
    167. Ford JM, Johnson MB, Whitfield SL, Faustman WO, Mathalon D. Delayed hemodynamic responses in schizophrenia. Neuroimage. 2005 Jul 01; 26(3):922-31. PMID: 15955502.
      View in: PubMed
    168. Heinks-Maldonado TH, Mathalon D, Gray M, Ford JM. Fine-tuning of auditory cortex during speech production. Psychophysiology. 2005 Mar; 42(2):180-90. PMID: 15787855.
      View in: PubMed
    169. Daurignac E, Toga A, Jones D, Aronen H, Hommer D, Jemigan T, Krystal J, Mathalon D. Applications of morphometric and diffusion tensor magnetic resonance imaging to the study of brain abnormalities in the alcoholism spectrum. Alcohol Clin Exp Res. 2005 Jan; 29(1):159-166. PMID: 15895490.
      View in: PubMed
    170. Mathalon D, Heinks T, Ford JM. Selective attention in schizophrenia: sparing and loss of executive control. Am J Psychiatry. 2004 May; 161(5):872-81. PMID: 15121653.
      View in: PubMed
    171. Ford JM, Gray M, Whitfield SL, Turken AU, Glover G, Faustman WO, Mathalon D. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry. 2004 Feb; 61(2):119-29. PMID: 14757588.
      View in: PubMed
    172. Ford JM, Mathalon D. Electrophysiological evidence of corollary discharge dysfunction in schizophrenia during talking and thinking. J Psychiatr Res. 2004 Jan; 38(1):37-46. PMID: 14690769.
      View in: PubMed
    173. Turken AU, Vuilleumier P, Mathalon D, Swick D, Ford JM. Are impairments of action monitoring and executive control true dissociative dysfunctions in patients with schizophrenia? Am J Psychiatry. 2003 Oct; 160(10):1881-3. PMID: 14514505.
      View in: PubMed
    174. Mathalon D, Whitfield SL, Ford JM. Anatomy of an error: ERP and fMRI. Biol Psychol. 2003 Oct; 64(1-2):119-41. PMID: 14602358.
      View in: PubMed
    175. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl). 2003 Sep; 169(3-4):215-33. PMID: 12955285.
      View in: PubMed
    176. Mathalon D, Bennett A, Askari N, Gray EM, Rosenbloom MJ, Ford JM. Response-monitoring dysfunction in aging and Alzheimer's disease: an event-related potential study. Neurobiol Aging. 2003 Sep; 24(5):675-85. PMID: 12885575.
      View in: PubMed
    177. Mathalon D, Rapoport JL, Davis KL, Krystal JH. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. Arch Gen Psychiatry. 2003 Aug; 60(8):846-8; author reply 848-9. PMID: 12912768.
      View in: PubMed
    178. Mathalon D, Pfefferbaum A, Lim KO, Rosenbloom MJ, Sullivan EV. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch Gen Psychiatry. 2003 Mar; 60(3):245-52. PMID: 12622657.
      View in: PubMed
    179. Mathalon D, Faustman WO, Ford JM. N400 and automatic semantic processing abnormalities in patients with schizophrenia. Arch Gen Psychiatry. 2002 Jul; 59(7):641-8. PMID: 12090817.
      View in: PubMed
    180. Mathalon D, Ford JM. The long and the short of it: influence of interstimulus interval on auditory P300 abnormalities in schizophrenia. Clin Electroencephalogr. 2002 Jul; 33(3):125-35. PMID: 12192662.
      View in: PubMed
    181. Ford JM, Mathalon D, Whitfield S, Faustman WO, Roth WT. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry. 2002 Mar 15; 51(6):485-92. PMID: 11922884.
      View in: PubMed
    182. Mathalon D, Fedor M, Faustman WO, Gray M, Askari N, Ford JM. Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol. 2002 Feb; 111(1):22-41. PMID: 11866176.
      View in: PubMed
    183. Ford JM, Mathalon D, Heinks T, Kalba S, Faustman WO, Roth WT. Neurophysiological evidence of corollary discharge dysfunction in schizophrenia. Am J Psychiatry. 2001 Dec; 158(12):2069-71. PMID: 11729029.
      View in: PubMed
    184. Ford JM, Mathalon D, Kalba S, Whitfield S, Faustman WO, Roth WT. Cortical responsiveness during inner speech in schizophrenia: an event-related potential study. Am J Psychiatry. 2001 Nov; 158(11):1914-6. PMID: 11691701.
      View in: PubMed
    185. Ford JM, Mathalon D, Kalba S, Whitfield S, Faustman WO, Roth WT. Cortical responsiveness during talking and listening in schizophrenia: an event-related brain potential study. Biol Psychiatry. 2001 Oct 01; 50(7):540-9. PMID: 11600107.
      View in: PubMed
    186. Ford JM, Mathalon D, Kalba S, Marsh L, Pfefferbaum A. N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features. Biol Psychiatry. 2001 May 15; 49(10):848-60. PMID: 11343681.
      View in: PubMed
    187. Menon V, Anagnoson RT, Mathalon D, Glover GH, Pfefferbaum A. Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. Neuroimage. 2001 Mar; 13(3):433-46. PMID: 11170809.
      View in: PubMed
    188. Ford JM, Askari N, Mathalon D, Menon V, Gabrieli JD, Tinklenberg JR, Yesavage J. Event-related brain potential evidence of spared knowledge in Alzheimer's disease. Psychol Aging. 2001 Mar; 16(1):161-76. PMID: 11302364.
      View in: PubMed
    189. Mathalon D, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001 Feb; 58(2):148-57. PMID: 11177116.
      View in: PubMed
    190. Ford JM, Mathalon D, White PM, Pfefferbaum A. Left temporal deficit of P300 in patients with schizophrenia: effects of task. Int J Psychophysiol. 2000 Oct; 38(1):71-9. PMID: 11027795.
      View in: PubMed
    191. Sullivan EV, Deshmukh A, Desmond JE, Mathalon D, Rosenbloom MJ, Lim KO, Pfefferbaum A. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch Gen Psychiatry. 2000 Sep; 57(9):894-902. PMID: 10986553.
      View in: PubMed
    192. Mathalon D, Ford JM, Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol Psychiatry. 2000 Mar 01; 47(5):434-49. PMID: 10704955.
      View in: PubMed
    193. Mathalon D, Ford JM, Rosenbloom M, Pfefferbaum A. P300 reduction and prolongation with illness duration in schizophrenia. Biol Psychiatry. 2000 Mar 01; 47(5):413-27. PMID: 10704953.
      View in: PubMed
    194. Ford JM, Mathalon D, Marsh L, Faustman WO, Harris D, Hoff AL, Beal M, Pfefferbaum A. P300 amplitude is related to clinical state in severely and moderately ill patients with schizophrenia. Biol Psychiatry. 1999 Jul 01; 46(1):94-101. PMID: 10394478.
      View in: PubMed
    195. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Mathalon D, Lim KO. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry. 1998 Oct; 55(10):905-12. PMID: 9783561.
      View in: PubMed
    196. Lauriello J, Mathalon D, Rosenbloom M, Sullivan EV, Faustman WO, Ringo DL, Lim KO, Pfefferbaum A. Association between regional brain volumes and clozapine response in schizophrenia. Biol Psychiatry. 1998 Jun 15; 43(12):879-86. PMID: 9627742.
      View in: PubMed
    197. Sullivan EV, Lim KO, Mathalon D, Marsh L, Beal DM, Harris D, Hoff AL, Faustman WO, Pfefferbaum A. A profile of cortical gray matter volume deficits characteristic of schizophrenia. Cereb Cortex. 1998 Mar; 8(2):117-24. PMID: 9542891.
      View in: PubMed
    198. Sullivan EV, Mathalon D, Lim KO, Marsh L, Pfefferbaum A. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism. Biol Psychiatry. 1998 Jan 15; 43(2):118-31. PMID: 9474444.
      View in: PubMed
    199. Pfefferbaum A, Sullivan EV, Mathalon D, Lim KO. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res. 1997 May; 21(3):521-9. PMID: 9161613.
      View in: PubMed
    200. Sullivan EV, Marsh L, Mathalon D, Lim KO, Pfefferbaum A. Relationship between alcohol withdrawal seizures and temporal lobe white matter volume deficits. Alcohol Clin Exp Res. 1996 Apr; 20(2):348-54. PMID: 8730229.
      View in: PubMed
    201. Pfefferbaum A, Sullivan EV, Mathalon D, Shear PK, Rosenbloom MJ, Lim KO. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res. 1995 Oct; 19(5):1177-91. PMID: 8561288.
      View in: PubMed
    202. Sullivan EV, Marsh L, Mathalon D, Lim KO, Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging. 1995 Jul-Aug; 16(4):591-606. PMID: 8544910.
      View in: PubMed
    203. Shear PK, Sullivan EV, Mathalon D, Lim KO, Davis LF, Yesavage JA, Tinklenberg JR, Pfefferbaum A. Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Arch Neurol. 1995 Apr; 52(4):392-402. PMID: 7710375.
      View in: PubMed
    204. Sullivan EV, Marsh L, Mathalon D, Lim KO, Pfefferbaum A. Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol Clin Exp Res. 1995 Feb; 19(1):110-22. PMID: 7771636.
      View in: PubMed
    205. Pfefferbaum A, Mathalon D, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994 Sep; 51(9):874-87. PMID: 8080387.
      View in: PubMed
    206. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Shear PK, Mathalon D, Lim KO. Increase in brain cerebrospinal fluid volume is greater in older than in younger alcoholic patients: a replication study and CT/MRI comparison. Psychiatry Res. 1993 Dec; 50(4):257-74. PMID: 8177924.
      View in: PubMed
    207. Mathalon D, Sullivan EV, Rawles JM, Pfefferbaum A. Correction for head size in brain-imaging measurements. Psychiatry Res. 1993 Jun; 50(2):121-39. PMID: 8378488.
      View in: PubMed
    208. Sullivan EV, Shear PK, Mathalon D, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A. Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease. Arch Neurol. 1993 Apr; 50(4):359-73. PMID: 8460957.
      View in: PubMed
    209. Sullivan EV, Mathalon D, Zipursky RB, Kersteen-Tucker Z, Knight RT, Pfefferbaum A. Factors of the Wisconsin Card Sorting Test as measures of frontal-lobe function in schizophrenia and in chronic alcoholism. Psychiatry Res. 1993 Feb; 46(2):175-99. PMID: 8483976.
      View in: PubMed
    210. Pfefferbaum A, Lim KO, Zipursky RB, Mathalon D, Rosenbloom MJ, Lane B, Ha CN, Sullivan EV. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res. 1992 Dec; 16(6):1078-89. PMID: 1471762.
      View in: PubMed
    211. Sullivan EV, Mathalon D, Ha CN, Zipursky RB, Pfefferbaum A. The contribution of constructional accuracy and organizational strategy to nonverbal recall in schizophrenia and chronic alcoholism. Biol Psychiatry. 1992 Aug 15; 32(4):312-33. PMID: 1420646.
      View in: PubMed
    212. Pfefferbaum A, Ford JM, White PM, Mathalon D. Event-related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption. Alcohol Clin Exp Res. 1991 Oct; 15(5):839-50. PMID: 1755518.
      View in: PubMed
    Daniel's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP